Kenneth R. Chien

Kenneth R. Chien (born 1951) is an American doctor and medical scientist who has been a research director at the Karolinska Institute in Stockholm since 2013. Chien has several papers with over 1,000 citations and an H-index of 132. His area of expertise is in cardiovascular science. His research into regenerative cardiovascular medicine, specifically while acting as director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding of ModeRNA Therapeutics in 2010. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the University of Edinburgh. Provided by Wikipedia